Cardiovascular mortality in chronic renal failure: Hyperphosphatemia, coronary calcification, and the role of phosphate binders

Richard A. Fatica, MD
Department of Nephrology and Hypertension, The Cleveland Clinic

Vincent W. Dennis, MD
Chairman, Department of Nephrology and Hypertension, The Cleveland Clinic

Correspondence: Richard A. Fatica, MD, Department of Nephrology and Hypertension, Desk A51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail faticar@ccf.org

Both authors have indicated that they have no affiliation with or financial interest in a commercial organization that poses a potential conflict of interest with their article.

Richard A. Fatica, MD
Department of Nephrology and Hypertension, The Cleveland Clinic

Vincent W. Dennis, MD
Chairman, Department of Nephrology and Hypertension, The Cleveland Clinic

Correspondence: Richard A. Fatica, MD, Department of Nephrology and Hypertension, Desk A51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail faticar@ccf.org

Both authors have indicated that they have no affiliation with or financial interest in a commercial organization that poses a potential conflict of interest with their article.

Richard A. Fatica, MD
Department of Nephrology and Hypertension, The Cleveland Clinic

Vincent W. Dennis, MD
Chairman, Department of Nephrology and Hypertension, The Cleveland Clinic

Correspondence: Richard A. Fatica, MD, Department of Nephrology and Hypertension, Desk A51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail faticar@ccf.org

Both authors have indicated that they have no affiliation with or financial interest in a commercial organization that poses a potential conflict of interest with their article.